DDRGK1

DDRGK domain containing 1

Basic information

Region (hg38): 20:3190350-3204685

Previous symbols: [ "C20orf116" ]

Links

ENSG00000198171NCBI:65992OMIM:616177HGNC:16110Uniprot:Q96HY6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spondyloepimetaphyseal dysplasia, Shohat type (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spondyloepimetaphyseal dysplasia, Shohat typeARPulmonaryThe condition may include a narrow trachea resulting in upper airway obstruction, and awareness may allow interventions to decrease morbidity and mortalityMusculoskeletal; Pulmonary28263186

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DDRGK1 gene.

  • not_provided (101 variants)
  • Inborn_genetic_diseases (50 variants)
  • DDRGK1-related_disorder (3 variants)
  • Spondyloepimetaphyseal_dysplasia,_Shohat_type (2 variants)
  • Hyperphosphatasia_with_intellectual_disability_syndrome_2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DDRGK1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000023935.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
27
clinvar
3
clinvar
30
missense
73
clinvar
3
clinvar
1
clinvar
77
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
Total 2 1 73 30 4

Highest pathogenic variant AF is 0.000007008423

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DDRGK1protein_codingprotein_codingENST00000354488 914336
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.07e-70.7781257160311257470.000123
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5571731950.8880.00001301966
Missense in Polyphen8288.1040.93072848
Synonymous0.7616775.40.8880.00000434643
Loss of Function1.351319.40.6690.00000114200

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005800.0000580
Ashkenazi Jewish0.000.00
East Asian0.00005480.0000544
Finnish0.00009470.0000924
European (Non-Finnish)0.00009880.0000967
Middle Eastern0.00005480.0000544
South Asian0.0004890.000457
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Protein which interacts with the E3 UFM1-protein ligase UFL1 and one of its substrates TRIP4 and is required for TRIP4 ufmylation. Through TRIP4 ufmylation may regulate nuclear receptors-mediated transcription (PubMed:25219498). May play a role in NF-kappa-B-mediated transcription through regulation of the phosphorylation and the degradation of NFKBIA, the inhibitor of NF-kappa-B (PubMed:23675531). May also play a role in the cellular response to endoplasmic reticulum stress (By similarity). Plays a role in cartilage development through SOX9, inhibiting the ubiquitin-mediated proteasomal degradation of this transcriptional regulator (PubMed:28263186). {ECO:0000250|UniProtKB:Q80WW9, ECO:0000269|PubMed:23675531, ECO:0000269|PubMed:25219498, ECO:0000269|PubMed:28263186}.;
Disease
DISEASE: Spondyloepimetaphyseal dysplasia, Shohat type (SEMDSH) [MIM:602557]: An autosomal recessive skeletal dysplasia that affects cartilage development. It is characterized by vertebral, epiphyseal, and metaphyseal abnormalities, including scoliosis with vertebral compression fractures, flattened vertebral bodies, and hypomineralization of long bones. Affected individuals may exhibit a small trunk, short neck, small limbs, joint laxity, bowlegs, and/or abdominal distension with hepatosplenomegaly. {ECO:0000269|PubMed:28263186}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0868

Intolerance Scores

loftool
0.678
rvis_EVS
0.17
rvis_percentile_EVS
65.76

Haploinsufficiency Scores

pHI
0.0547
hipred
Y
hipred_score
0.626
ghis
0.472

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.818

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ddrgk1
Phenotype
hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype;

Zebrafish Information Network

Gene name
ddrgk1
Affected structure
ceratobranchial cartilage
Phenotype tag
abnormal
Phenotype quality
absent

Gene ontology

Biological process
positive regulation of cell population proliferation;positive regulation of gene expression;negative regulation of gene expression;positive regulation of cell migration;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of intracellular estrogen receptor signaling pathway;response to endoplasmic reticulum stress;negative regulation of apoptotic process;positive regulation of transcription by RNA polymerase II;positive regulation of NF-kappaB transcription factor activity;cartilage development;positive regulation of proteasomal protein catabolic process;positive regulation of cell cycle G1/S phase transition;positive regulation of I-kappaB phosphorylation;positive regulation of metallopeptidase activity;positive regulation of protein localization to endoplasmic reticulum;positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding;protein K69-linked ufmylation
Cellular component
nucleolus;cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane
Molecular function
RNA polymerase II repressing transcription factor binding;protein binding;ubiquitin-like protein ligase binding